Placeholder Banner

BIO Commends USDA-APHIS Regulatory Announcements

November 21, 2023
Media Contact
Lynne Headshot

The Department of Agriculture’s Animal and Plant Health Inspection Service recently announced exemptions from regulations under the Plant Protection Act for several categories of plants with genetic modification that could be achieved through conventional breeding. The agency also announced that its regulatory status reviews of 12 plants modified using genetic engineering posed no increased plant pest risk compared to other cultivated plants and declared them not subject to regulation under 7 CFR Part 340. In addition, the FDA, EPA and USDA issued a report on stakeholder comments on the Coordinated Framework for the Regulation of Biotechnology, in addition to plain-language information on agency roles, responsibilities and processes.

The following statement may be attributed to Beth Ellikidis, vice president for agriculture and environment at BIO.

“BIO is pleased to see this science-based and risk-proportionate action from USDA-APHIS. We thank the agency for its efforts to decrease the backlog of plants in the regulatory docket and allow innovations to reach farmers and consumers. Opinion research conducted by BIO shows that the public supports updating regulatory processes to allow agricultural biotechnology companies to commercialize innovative products more quickly.

“BIO also thanks the FDA, EPA and USDA for delivering on commitments made in President Biden’s Executive Order on Advancing Biotechnology and Biomanufacturing Innovation. We look forward to seeing continued progress under the executive order to identify regulatory inefficiencies, strengthen confidence in the regulatory process for products of biotechnology, and deliver the innovations needed to ensure food security and address our changing climate.”


Discover More
Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not agree to extend an intellectual property…
New Season of I am BIO Podcast to Showcase  Life-Changing Biotech Breakthroughs Launching February 27, spring 2024 season explores a new CRISPR therapy, advances in microbiome research, biotech for pets and more  WASHINGTON – (Feb. 23,…
The Creating Hope Reauthorization Act of 2024 was introduced in the House of Representatives this week. BIO CEO and President, Rachel King, made the following statement following the bill's introduction: "BIO strongly supports the House…